全文获取类型
收费全文 | 4543篇 |
免费 | 508篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 165篇 |
妇产科学 | 93篇 |
基础医学 | 452篇 |
口腔科学 | 43篇 |
临床医学 | 611篇 |
内科学 | 674篇 |
皮肤病学 | 106篇 |
神经病学 | 507篇 |
特种医学 | 97篇 |
外科学 | 429篇 |
综合类 | 41篇 |
一般理论 | 6篇 |
预防医学 | 593篇 |
眼科学 | 39篇 |
药学 | 290篇 |
中国医学 | 3篇 |
肿瘤学 | 850篇 |
出版年
2024年 | 4篇 |
2023年 | 38篇 |
2022年 | 57篇 |
2021年 | 137篇 |
2020年 | 91篇 |
2019年 | 126篇 |
2018年 | 190篇 |
2017年 | 150篇 |
2016年 | 156篇 |
2015年 | 184篇 |
2014年 | 257篇 |
2013年 | 322篇 |
2012年 | 461篇 |
2011年 | 470篇 |
2010年 | 234篇 |
2009年 | 221篇 |
2008年 | 280篇 |
2007年 | 284篇 |
2006年 | 281篇 |
2005年 | 239篇 |
2004年 | 248篇 |
2003年 | 182篇 |
2002年 | 148篇 |
2001年 | 21篇 |
2000年 | 22篇 |
1999年 | 27篇 |
1998年 | 31篇 |
1997年 | 27篇 |
1996年 | 11篇 |
1995年 | 23篇 |
1994年 | 7篇 |
1993年 | 13篇 |
1992年 | 12篇 |
1991年 | 12篇 |
1990年 | 11篇 |
1989年 | 10篇 |
1988年 | 6篇 |
1987年 | 8篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1977年 | 4篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1971年 | 4篇 |
1967年 | 3篇 |
1960年 | 2篇 |
排序方式: 共有5057条查询结果,搜索用时 15 毫秒
1.
2.
3.
Growth Hormone Induces Recurrence of Infantile Hemangiomas After Apparent Involution: Evidence of Growth Hormone Receptors in Infantile Hemangioma
下载免费PDF全文
![点击此处可从《Pediatric dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Naikhoba C. O. Munabi B.A. Qian Kun Tan H.S. Maria C. Garzon M.D. Gerald G. Behr M.D. Carrie J. Shawber Ph.D. June K. Wu M.D. 《Pediatric dermatology》2015,32(4):539-543
Infantile hemangiomas (IHs) are the most common benign tumor of infancy, characterized by a natural history of early proliferation in the first months of life to eventual involution during childhood, often with residual fibrofatty tissue. Once involution has been achieved, IHs do not typically recur. We present two cases of exogenous growth hormone therapy resulting in the recurrence of IHs in late childhood, supported by radiological, immunohistochemical, in vitro, and in vivo evidence. 相似文献
4.
5.
6.
7.
8.
9.
Anna P Schenck Carrie N Klabunde Joan L Warren Sharon Peacock William W Davis Sarah T Hawley Michael Pignone David F Ransohoff 《Cancer epidemiology, biomarkers & prevention》2007,16(10):2118-2127
BACKGROUND: Estimates of colorectal cancer test use vary widely by data source. Medicare claims offer one source for monitoring test use, but their utility has not been validated. We compared ascertainment of sigmoidoscopy and colonoscopy between three data sources: self reports, Medicare claims, and medical records. MATERIALS AND METHODS: The study population included Medicare enrollees residing in North Carolina (n = 561) who had participated in a telephone survey on colorectal cancer tests. Medicare claims were obtained for the 5 years preceding the survey (January 1, 1998 to December 31, 2002). Information about sigmoidoscopy and colonoscopy procedures conducted in physician offices were abstracted from medical records. Sensitivity, specificity, positive predictive value, negative predictive value, agreement, and kappa statistics were calculated using the medical record as the gold standard. Agreement on specific procedure type and purpose was also assessed. RESULTS: Agreement between claim and medical record regarding whether an endoscopic procedure had been done was high (over 90%). Agreement between self report and medical record and between self report and claim was good (79% and 74%, respectively). All three data sources adequately distinguished the type of procedure done. None of the data sources showed reliable levels of agreement regarding procedure purpose (screening or diagnostic). CONCLUSION: Medicare claims can provide accurate information on whether a patient has undergone colorectal endoscopy and may be more complete than physician medical records. Medicare claims cannot be used to distinguish screening from diagnostic tests. Recognizing this limitation, researchers who use Medicare claims to assess rates of colorectal testing should include both screening and diagnostic endoscopy procedures in their analyses. 相似文献
10.